Market Overview:
The global brompheniramine market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, rising awareness about the benefits of brompheniramine, and growing demand for over-the-counter drugs. Based on type, the global brompheniramine market can be segmented into oral solution and tablet. The oral solution segment is expected to account for a larger share of the market than the tablet segment during the forecast period. This can be attributed to its easy availability and lower price as compared to tablets. Based on application, the global brompheniramine market can be divided into hospital and drug store segments.
Product Definition:
Brompheniramine is an antihistamine drug used to relieve symptoms of allergy, hay fever, and the common cold. It is a member of the pheniramine family.
Oral Solution:
Oral solution is a form of drug delivery which is administered by mouth. It may be in the form of tablets or as a liquid. The drug absorbs into the blood vessels and is then carried to all areas of the body via the blood stream.
Tablet:
Tablet is a form of drug delivery technology that consists of compressed tablets containing the active ingredient. The drug is usually formulated in gelatin or other matrix material and then compressed with the help of specialized machinery. It can be easily divided into two portions, which are equal in size and shape with no difference in their content. These factors make it an ideal dosage form for children as well as adults alike.
Application Insights:
The drug store application segment dominated the global market in 2017. Brompheniramine is used for the treatment of allergic rhinitis, runny nose and itchy eyes caused due to different factors such as pollution, dust particles or animal dander. The product works by blocking the action of histamine on blood vessels resulting in reduced inflammation and pain.
Brompheniramine is available without a prescription in most countries worldwide but specialty pharmacies may carry different types of generic drugs with higher dosage than normal ones for more severe allergies such as asthma. In addition, these pharmacies also have other medicines that are not sold over-the-counter which are only available through a prescription from doctors or medical professionals including nasal sprays and allergy shots depending on what symptoms an individual suffers from when taking any medication.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period. This can be attributed to increasing cases of allergic rhinitis and other skin allergies among consumers, rising awareness about available treatment options, and presence of well-established healthcare facilities in this region.
Asia Pacific is expected to expand at the fastest CAGR during the forecast period owing to factors such as growing population with various skin disorders; improving healthcare infrastructure leading to an increase in consumer awareness about available treatment options;.
Growth Factors:
- Increasing prevalence of respiratory diseases such as asthma and bronchitis is expected to drive the growth of Brompheniramine market.
- Rising awareness about the benefits of Brompheniramine among patients is anticipated to fuel the demand for this drug in coming years.
- Growing number of research studies on Brompheniramine is likely to create new opportunities for this market in near future.
- increasing number of product launches by key players is projected to propel the growth of Brompheniramine market in next few years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Brompheniramine Market Research Report
By Type
Oral Solution, Tablet
By Application
Hospital, Drug Store
By Companies
Pfizer, AMAG Pharmaceuticals, PAI, USL Pharma, Watson Laboratories, Teva, Ivax Pharmaceuticals, Newtron Pharmaceuticals, Nexgen Pharma, Endo International, Novartis, Eon Pharma, Merck, Tanta Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
208
Number of Tables & Figures
146
Customization Available
Yes, the report can be customized as per your need.
Global Brompheniramine Market Report Segments:
The global Brompheniramine market is segmented on the basis of:
Types
Oral Solution, Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- AMAG Pharmaceuticals
- PAI
- USL Pharma
- Watson Laboratories
- Teva
- Ivax Pharmaceuticals
- Newtron Pharmaceuticals
- Nexgen Pharma
- Endo International
- Novartis
- Eon Pharma
- Merck
- Tanta Pharmaceuticals
Highlights of The Brompheniramine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Solution
- Tablet
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Brompheniramine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Brompheniramine is a medication used to treat allergies. It works by blocking the effects of histamines, which are chemicals that cause allergic reactions. Brompheniramine is usually taken in tablet form.
Some of the major companies in the brompheniramine market are Pfizer, AMAG Pharmaceuticals, PAI, USL Pharma, Watson Laboratories, Teva, Ivax Pharmaceuticals, Newtron Pharmaceuticals, Nexgen Pharma, Endo International, Novartis, Eon Pharma, Merck, Tanta Pharmaceuticals.
The brompheniramine market is expected to register a CAGR of 3.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Brompheniramine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Brompheniramine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Brompheniramine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Brompheniramine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Brompheniramine Market Size & Forecast, 2018-2028
4.5.1 Brompheniramine Market Size and Y-o-Y Growth
4.5.2 Brompheniramine Market Absolute $ Opportunity
Chapter 5 Global Brompheniramine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Brompheniramine Market Size Forecast by Type
5.2.1 Oral Solution
5.2.2 Tablet
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Brompheniramine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Brompheniramine Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Brompheniramine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Brompheniramine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Brompheniramine Analysis and Forecast
9.1 Introduction
9.2 North America Brompheniramine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Brompheniramine Market Size Forecast by Type
9.6.1 Oral Solution
9.6.2 Tablet
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Brompheniramine Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Brompheniramine Analysis and Forecast
10.1 Introduction
10.2 Europe Brompheniramine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Brompheniramine Market Size Forecast by Type
10.6.1 Oral Solution
10.6.2 Tablet
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Brompheniramine Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Brompheniramine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Brompheniramine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Brompheniramine Market Size Forecast by Type
11.6.1 Oral Solution
11.6.2 Tablet
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Brompheniramine Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Brompheniramine Analysis and Forecast
12.1 Introduction
12.2 Latin America Brompheniramine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Brompheniramine Market Size Forecast by Type
12.6.1 Oral Solution
12.6.2 Tablet
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Brompheniramine Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Brompheniramine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Brompheniramine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Brompheniramine Market Size Forecast by Type
13.6.1 Oral Solution
13.6.2 Tablet
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Brompheniramine Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Brompheniramine Market: Competitive Dashboard
14.2 Global Brompheniramine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 AMAG Pharmaceuticals
14.3.3 PAI
14.3.4 USL Pharma
14.3.5 Watson Laboratories
14.3.6 Teva
14.3.7 Ivax Pharmaceuticals
14.3.8 Newtron Pharmaceuticals
14.3.9 Nexgen Pharma
14.3.10 Endo International
14.3.11 Novartis
14.3.12 Eon Pharma
14.3.13 Merck
14.3.14 Tanta Pharmaceuticals
